← Browse by Condition
Medical Condition
parkinson s disease
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 3, Phase 1, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for parkinson s disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — parkinson s disease Clinical Trials
How many clinical trials are currently recruiting for parkinson s disease?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for parkinson s disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for parkinson s disease?
parkinson s disease research spans Phase 1 (2 trials), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a parkinson s disease clinical trial?
Eligibility criteria for parkinson s disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07509125
Recruiting
Enrollment
300 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT07174310 Phase 3
Recruiting
Enrollment
900 pts
Location
United States, Austr...
Sponsor
Hoffmann-La Roche
NCT07572903
Recruiting
Enrollment
90 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT07216976
Recruiting
Enrollment
62 pts
Location
China
Sponsor
MedtronicNeuro
NCT04396873 Phase 1
Recruiting
Enrollment
184 pts
Location
United States
Sponsor
National Institute of Mental H...
NCT07629115
Recruiting
Enrollment
6 pts
Location
South Korea
Sponsor
Innopeutics Corporation
NCT07533799
Recruiting
Enrollment
650 pts
Location
Sweden
Sponsor
Skane University Hospital
NCT07284719
Recruiting
Enrollment
20 pts
Location
Denmark
Sponsor
Aarhus University Hospital
NCT06937034
Recruiting
Enrollment
2,000 pts
Location
Austria, Netherlands...
Sponsor
AbbVie
NCT02994719
Recruiting
Enrollment
120 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
NCT06753331 Phase 1, Phase 2
Recruiting
Enrollment
25 pts
Location
United States
Sponsor
Sumitomo Pharma America, Inc.
Related Conditions
rem sleep behavior disorder irbd (2) alzheimer dementia ad (1) als amyotrophic lateral sclerosis (1) psp progressive supranuclear palsy (1) msa multiple system atrophy (1) dementia with lewy bodies dlb (1) als with frontotemporal dementia als ftd (1) adult onset psychotic disorder (1) very late onset psychotic disorder (1) dementia (1) alzheimer s disease (1) als (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology